Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

A COMPREHENSIVE ANALYSIS OF GENOME COMPOSITION AND CODON USAGE PATTERNS OF EMERGING CORONAVIRUSES.

Identifieur interne : 000108 ( PubMed/Corpus ); précédent : 000107; suivant : 000109

A COMPREHENSIVE ANALYSIS OF GENOME COMPOSITION AND CODON USAGE PATTERNS OF EMERGING CORONAVIRUSES.

Auteurs : Fernando L. Tort ; Matías Castells ; Juan Cristina

Source :

RBID : pubmed:32294518

Abstract

An outbreak of atypical pneumonia caused by a novel Betacoronavirus (βCoV), named SARS-CoV-2 has been declared a public health emergency of international concern by the World Health Organization. In order to gain insight into the emergence, evolution and adaptation of SARS-CoV-2 viruses, a comprehensive analysis of genome composition and codon usage of βCoV circulating in China was performed. A biased nucleotide composition was found for SARS-CoV-2 genome. This bias in genomic composition is reflected in its codon and amino acid usage patterns. The overall codon usage in SARS-CoV-2 is similar among themselves and slightly biased. Most of the highly frequent codons are A- and U-ending, which strongly suggests that mutational bias is the main force shaping codon usage in this virus. Significant differences in relative synonymous codon usage frequencies among SARS-CoV-2 and human cells were found. These differences are due to codon usage preferences.

DOI: 10.1016/j.virusres.2020.197976
PubMed: 32294518

Links to Exploration step

pubmed:32294518

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">A COMPREHENSIVE ANALYSIS OF GENOME COMPOSITION AND CODON USAGE PATTERNS OF EMERGING CORONAVIRUSES.</title>
<author>
<name sortKey="Tort, Fernando L" sort="Tort, Fernando L" uniqKey="Tort F" first="Fernando L" last="Tort">Fernando L. Tort</name>
<affiliation>
<nlm:affiliation>Laboratorio de Virología Molecular, Sede Salto, Centro Universitario Regional, Litoral Norte, Universidad de la República, Gral. Rivera 1350, 50000, Salto, Uruguay.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Castells, Matias" sort="Castells, Matias" uniqKey="Castells M" first="Matías" last="Castells">Matías Castells</name>
<affiliation>
<nlm:affiliation>Laboratorio de Virología Molecular, Sede Salto, Centro Universitario Regional, Litoral Norte, Universidad de la República, Gral. Rivera 1350, 50000, Salto, Uruguay.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Cristina, Juan" sort="Cristina, Juan" uniqKey="Cristina J" first="Juan" last="Cristina">Juan Cristina</name>
<affiliation>
<nlm:affiliation>Laboratorio de Virología Molecular, Centro de Investigaciones Nucleares, Facultad de Ciencias, Universidad de la República, Iguá 4225, Montevideo, 11400, Uruguay. Electronic address: cristina@cin.edu.uy.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32294518</idno>
<idno type="pmid">32294518</idno>
<idno type="doi">10.1016/j.virusres.2020.197976</idno>
<idno type="wicri:Area/PubMed/Corpus">000108</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000108</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">A COMPREHENSIVE ANALYSIS OF GENOME COMPOSITION AND CODON USAGE PATTERNS OF EMERGING CORONAVIRUSES.</title>
<author>
<name sortKey="Tort, Fernando L" sort="Tort, Fernando L" uniqKey="Tort F" first="Fernando L" last="Tort">Fernando L. Tort</name>
<affiliation>
<nlm:affiliation>Laboratorio de Virología Molecular, Sede Salto, Centro Universitario Regional, Litoral Norte, Universidad de la República, Gral. Rivera 1350, 50000, Salto, Uruguay.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Castells, Matias" sort="Castells, Matias" uniqKey="Castells M" first="Matías" last="Castells">Matías Castells</name>
<affiliation>
<nlm:affiliation>Laboratorio de Virología Molecular, Sede Salto, Centro Universitario Regional, Litoral Norte, Universidad de la República, Gral. Rivera 1350, 50000, Salto, Uruguay.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Cristina, Juan" sort="Cristina, Juan" uniqKey="Cristina J" first="Juan" last="Cristina">Juan Cristina</name>
<affiliation>
<nlm:affiliation>Laboratorio de Virología Molecular, Centro de Investigaciones Nucleares, Facultad de Ciencias, Universidad de la República, Iguá 4225, Montevideo, 11400, Uruguay. Electronic address: cristina@cin.edu.uy.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Virus research</title>
<idno type="eISSN">1872-7492</idno>
<imprint>
<date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">An outbreak of atypical pneumonia caused by a novel Betacoronavirus (βCoV), named SARS-CoV-2 has been declared a public health emergency of international concern by the World Health Organization. In order to gain insight into the emergence, evolution and adaptation of SARS-CoV-2 viruses, a comprehensive analysis of genome composition and codon usage of βCoV circulating in China was performed. A biased nucleotide composition was found for SARS-CoV-2 genome. This bias in genomic composition is reflected in its codon and amino acid usage patterns. The overall codon usage in SARS-CoV-2 is similar among themselves and slightly biased. Most of the highly frequent codons are A- and U-ending, which strongly suggests that mutational bias is the main force shaping codon usage in this virus. Significant differences in relative synonymous codon usage frequencies among SARS-CoV-2 and human cells were found. These differences are due to codon usage preferences.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="Publisher" Owner="NLM">
<PMID Version="1">32294518</PMID>
<DateRevised>
<Year>2020</Year>
<Month>04</Month>
<Day>17</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1872-7492</ISSN>
<JournalIssue CitedMedium="Internet">
<PubDate>
<Year>2020</Year>
<Month>Apr</Month>
<Day>12</Day>
</PubDate>
</JournalIssue>
<Title>Virus research</Title>
<ISOAbbreviation>Virus Res.</ISOAbbreviation>
</Journal>
<ArticleTitle>A COMPREHENSIVE ANALYSIS OF GENOME COMPOSITION AND CODON USAGE PATTERNS OF EMERGING CORONAVIRUSES.</ArticleTitle>
<Pagination>
<MedlinePgn>197976</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0168-1702(20)30168-4</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.virusres.2020.197976</ELocationID>
<Abstract>
<AbstractText>An outbreak of atypical pneumonia caused by a novel Betacoronavirus (βCoV), named SARS-CoV-2 has been declared a public health emergency of international concern by the World Health Organization. In order to gain insight into the emergence, evolution and adaptation of SARS-CoV-2 viruses, a comprehensive analysis of genome composition and codon usage of βCoV circulating in China was performed. A biased nucleotide composition was found for SARS-CoV-2 genome. This bias in genomic composition is reflected in its codon and amino acid usage patterns. The overall codon usage in SARS-CoV-2 is similar among themselves and slightly biased. Most of the highly frequent codons are A- and U-ending, which strongly suggests that mutational bias is the main force shaping codon usage in this virus. Significant differences in relative synonymous codon usage frequencies among SARS-CoV-2 and human cells were found. These differences are due to codon usage preferences.</AbstractText>
<CopyrightInformation>Copyright © 2020. Published by Elsevier B.V.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Tort</LastName>
<ForeName>Fernando L</ForeName>
<Initials>FL</Initials>
<AffiliationInfo>
<Affiliation>Laboratorio de Virología Molecular, Sede Salto, Centro Universitario Regional, Litoral Norte, Universidad de la República, Gral. Rivera 1350, 50000, Salto, Uruguay.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Castells</LastName>
<ForeName>Matías</ForeName>
<Initials>M</Initials>
<AffiliationInfo>
<Affiliation>Laboratorio de Virología Molecular, Sede Salto, Centro Universitario Regional, Litoral Norte, Universidad de la República, Gral. Rivera 1350, 50000, Salto, Uruguay.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Cristina</LastName>
<ForeName>Juan</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Laboratorio de Virología Molecular, Centro de Investigaciones Nucleares, Facultad de Ciencias, Universidad de la República, Iguá 4225, Montevideo, 11400, Uruguay. Electronic address: cristina@cin.edu.uy.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2020</Year>
<Month>04</Month>
<Day>12</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Virus Res</MedlineTA>
<NlmUniqueID>8410979</NlmUniqueID>
<ISSNLinking>0168-1702</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">2019-nCoV</Keyword>
<Keyword MajorTopicYN="N">Coronavirus</Keyword>
<Keyword MajorTopicYN="N">SARS-CoV-2</Keyword>
<Keyword MajorTopicYN="N">Wuhan</Keyword>
<Keyword MajorTopicYN="N">codon usage</Keyword>
<Keyword MajorTopicYN="N">evolution</Keyword>
</KeywordList>
<CoiStatement>Declaration of Competing Interest None.</CoiStatement>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2020</Year>
<Month>02</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2020</Year>
<Month>04</Month>
<Day>08</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2020</Year>
<Month>04</Month>
<Day>08</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2020</Year>
<Month>4</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2020</Year>
<Month>4</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2020</Year>
<Month>4</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">32294518</ArticleId>
<ArticleId IdType="pii">S0168-1702(20)30168-4</ArticleId>
<ArticleId IdType="doi">10.1016/j.virusres.2020.197976</ArticleId>
<ArticleId IdType="pmc">PMC7152894</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Mol Biol Evol. 2018 Jun 1;35(6):1547-1549</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29722887</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virol J. 2017 Jun 17;14(1):115</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28623921</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Gen Virol. 2016 Oct;97(10):2608-2619</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27519195</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nature. 2018 Apr;556(7700):255-258</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29618817</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virol J. 2004 Nov 17;1:7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15548333</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virus Res. 2015 Apr 16;202:41-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25656063</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nucleic Acids Res. 2015 Jul 1;43(W1):W566-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25969447</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Trends Microbiol. 2016 Jun;24(6):490-502</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27012512</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Biol Pharm Bull. 2017;40(8):1289-1298</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28769010</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virus Res. 2003 Mar;92(1):1-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12606071</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nucleic Acids Res. 2018 Jul 2;46(W1):W537-W544</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29790989</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nucleic Acids Res. 1987 Feb 11;15(3):1281-95</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3547335</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Gene. 1990 Mar 1;87(1):23-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2110097</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Med Virol. 2020 Jan;92(1):1-3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">31502247</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virus Res. 2007 Jun;126(1-2):196-206</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17434639</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virus Res. 2004 May;101(2):155-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15041183</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Rev Microbiol. 2019 Mar;17(3):181-192</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30531947</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virology. 2017 Jul;507:1-10</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28384506</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>RNA Biol. 2013 Feb;10(2):211-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23235488</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virus Res. 2013 Dec 26;178(2):264-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24091362</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Arch Virol. 2011 Jan;156(1):153-60</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21069395</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Mol Evol. 1986;24(1-2):28-38</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">3104616</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Br Vet J. 1993 Jan-Feb;149(1):51-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8382546</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Med. 2004 Dec;10(12 Suppl):S88-97</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15577937</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Oncotarget. 2017 Nov 27;8(66):110337-110349</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29299151</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Vet Res. 2007 Mar-Apr;38(2):281-97</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17296157</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virus Res. 2014 Nov 26;193:16-23</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24675274</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virology. 2007 Dec 20;369(2):431-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17881030</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000108 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000108 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:32294518
   |texte=   A COMPREHENSIVE ANALYSIS OF GENOME COMPOSITION AND CODON USAGE PATTERNS OF EMERGING CORONAVIRUSES.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:32294518" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021